Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Emberton

Showing results (431-440 of 475) with videos related to

Pageof 48
Sort By:
Prostate International|July 1, 2026
Irreversible electroporation in focal therapy for prostate cancer: current status and future directionsFrancisco O Durazo-Ruiz, Rocío Roldán-Testillano, Lara Rodriguez-Sanchez, et al.
European Urology|December 12, 2018
The SmartTarget Biopsy Trial: A Prospective, Within-person Randomised, Blinded Trial Comparing the Accuracy of Visual-registration and Magnetic Resonance Imaging/Ultrasound Image-fusion Targeted Biopsies for Prostate Cancer Risk StratificationSami Hamid, Ian A Donaldson, Yipeng Hu, et al.
The Journal of Urology|November 23, 2016
The Effect of Dutasteride on Magnetic Resonance Imaging Defined Prostate Cancer: MAPPED-A Randomized, Placebo Controlled, Double-Blind Clinical TrialCaroline M Moore, Nicola L Robertson, Fatima Jichi, et al.
BMC Cancer|October 23, 2016
INNOVATE: A prospective cohort study combining serum and urinary biomarkers with novel diffusion-weighted magnetic resonance imaging for the prediction and characterization of prostate cancerEdward Johnston, Hayley Pye, Elisenda Bonet-Carne, et al.
Journal of Magnetic Resonance Imaging : JMRI|October 31, 2022
Quantification of Prostate Cancer Metabolism Using 3D Multiecho bSSFP and Hyperpolarized [1-<sup>13</sup> C] Pyruvate: Metabolism Differs Between Tumors of the Same Gleason GradeRafat Chowdhury, Christoph A Mueller, Lorna Smith, et al.
The Lancet. Oncology|December 24, 2016
Padeliporfin vascular-targeted photodynamic therapy versus active surveillance in men with low-risk prostate cancer (CLIN1001 PCM301): an open-label, phase 3, randomised controlled trialAbdel-Rahmène Azzouzi, Sébastien Vincendeau, Eric Barret, et al.
Journal of Medical Economics|September 1, 2023
Focal therapy versus radical prostatectomy and external beam radiotherapy as primary treatment options for non-metastatic prostate cancer: results of a cost-effectiveness analysisDeepika Reddy, Marieke van Son, Max Peters, et al.
BJR Case Reports|August 21, 2019
First-in-human <i>in vivo</i> non-invasive assessment of intra-tumoral metabolic heterogeneity in renal cell carcinomaMaxine Tran, Arash Latifoltojar, Joana B Neves, et al.
Prostate Cancer and Prostatic Diseases|January 15, 2020
"TREXIT 2020": why the time to abandon transrectal prostate biopsy starts nowJeremy Grummet, Michael A Gorin, Rick Popert, et al.
The Prostate|August 4, 2018
Immunohistochemical biomarker validation in highly selective needle biopsy microarrays derived from mpMRI-characterized prostatesJonathan Olivier, Vasilis Stavrinides, Jonathan Kay, et al.
Pageof 48

Showing results (431-440 of 475) with videos related to

Sort By:
Pageof 48
Prostate International|July 1, 2026
Irreversible electroporation in focal therapy for prostate cancer: current status and future directionsFrancisco O Durazo-Ruiz, Rocío Roldán-Testillano, Lara Rodriguez-Sanchez, et al.
European Urology|December 12, 2018
The SmartTarget Biopsy Trial: A Prospective, Within-person Randomised, Blinded Trial Comparing the Accuracy of Visual-registration and Magnetic Resonance Imaging/Ultrasound Image-fusion Targeted Biopsies for Prostate Cancer Risk StratificationSami Hamid, Ian A Donaldson, Yipeng Hu, et al.
The Journal of Urology|November 23, 2016
The Effect of Dutasteride on Magnetic Resonance Imaging Defined Prostate Cancer: MAPPED-A Randomized, Placebo Controlled, Double-Blind Clinical TrialCaroline M Moore, Nicola L Robertson, Fatima Jichi, et al.
BMC Cancer|October 23, 2016
INNOVATE: A prospective cohort study combining serum and urinary biomarkers with novel diffusion-weighted magnetic resonance imaging for the prediction and characterization of prostate cancerEdward Johnston, Hayley Pye, Elisenda Bonet-Carne, et al.
Journal of Magnetic Resonance Imaging : JMRI|October 31, 2022
Quantification of Prostate Cancer Metabolism Using 3D Multiecho bSSFP and Hyperpolarized [1-<sup>13</sup> C] Pyruvate: Metabolism Differs Between Tumors of the Same Gleason GradeRafat Chowdhury, Christoph A Mueller, Lorna Smith, et al.
The Lancet. Oncology|December 24, 2016
Padeliporfin vascular-targeted photodynamic therapy versus active surveillance in men with low-risk prostate cancer (CLIN1001 PCM301): an open-label, phase 3, randomised controlled trialAbdel-Rahmène Azzouzi, Sébastien Vincendeau, Eric Barret, et al.
Journal of Medical Economics|September 1, 2023
Focal therapy versus radical prostatectomy and external beam radiotherapy as primary treatment options for non-metastatic prostate cancer: results of a cost-effectiveness analysisDeepika Reddy, Marieke van Son, Max Peters, et al.
BJR Case Reports|August 21, 2019
First-in-human <i>in vivo</i> non-invasive assessment of intra-tumoral metabolic heterogeneity in renal cell carcinomaMaxine Tran, Arash Latifoltojar, Joana B Neves, et al.
Prostate Cancer and Prostatic Diseases|January 15, 2020
"TREXIT 2020": why the time to abandon transrectal prostate biopsy starts nowJeremy Grummet, Michael A Gorin, Rick Popert, et al.
The Prostate|August 4, 2018
Immunohistochemical biomarker validation in highly selective needle biopsy microarrays derived from mpMRI-characterized prostatesJonathan Olivier, Vasilis Stavrinides, Jonathan Kay, et al.
Pageof 48